Bravecto Plus Flea, Tick and Worm Treatment for Medium Cats

Bravecto Plus is a topical spot-on medication specifically formulated for cats to provide broad-spectrum protection against fleas, paralysis ticks, heartworm, and intestinal worms.

The Bravecto brand was developed by Intervet (now MSD Animal Health / Merck Animal Health), an international veterinary pharmaceutical company. The active ingredient fluralaner was innovated through veterinary research under MSD Animal Health.

Bravecto is owned and marketed globally by Merck & Co., Inc. (known as MSD outside the United States and Canada), a leading multinational pharmaceutical corporation headquartered in Rahway, New Jersey, USA. In Australia, the product is registered and distributed by Intervet Australia Pty Ltd (trading as MSD Animal Health). Depending on the specific batch and component packaging, manufacturing takes place in global pharmaceutical facilities across Europe and the United States.